CRISPR Gene Editing: Breaking Barriers for Rare Disease Treatment
June 12, 2026
Rare diseases, with low incidence and complex pathogenesis, have long been known as “intractable diseases” in medicine. Most rare diseases
China Pharma Insights
Designed for medical practitioners, industry researchers, and healthcare professionals, this series bridges the gap between cutting-edge medical research and real-world clinical application. It systematically interprets innovative treatment technologies, updated medical guidelines, breakthrough drug developments, and transformative healthcare models, helping readers quickly grasp evolving medical frontiers.
Latest News
Health Equity: The Core Trend of Global Medical Development in 2026
June 12, 2026
Global medical development is undergoing a profound structural change in 2026, with health equity officially moving from a marginal social
Gut Microbiome: The Hidden Regulator of Human Health and Disease
June 12, 2026
The human gut microbiome, known as the “second genome”, plays a core regulatory role in human metabolism, immunity, nervous system
How Generative AI Is Reshaping Modern Clinical Practice
Artificial intelligence has evolved from an experimental medical tool to a core clinical assistant in 2026, with generative AI leading
June 12, 2026
Precision Medicine: Shifting from Disease Treatment to Individualized Health Management
2026 witnesses a comprehensive paradigm shift in global medicine, with the medical model gradually transforming from the traditional “disease-centered” passive
June 12, 2026
Breakthroughs in Neurological Disease Treatment: New Hope for Multiple Sclerosis and Neurodegenerative Disorders
Neurological diseases, represented by multiple sclerosis (MS) and neurodegenerative disorders, have long been difficult clinical problems due to their complex
June 12, 2026
A Cost-Effective Strategy to Accelerate Clinical Treatment Innovation
New drug research and development is characterized by long cycle, high cost and high risk, which makes it difficult for
June 12, 2026
New Progress in Cardiorenal Metabolic Disease Treatment
Cardiorenal metabolic diseases including cardiovascular diseases, diabetic nephropathy and lipid metabolism disorders are the leading causes of global chronic disease
June 12, 2026
Health Equity: The Core Trend of Global Medical Development in 2026
Global medical development is undergoing a profound structural change in 2026, with health equity officially moving from a marginal social
June 12, 2026
Gut Microbiome: The Hidden Regulator of Human Health and Disease
The human gut microbiome, known as the “second genome”, plays a core regulatory role in human metabolism, immunity, nervous system
June 12, 2026